Clobazam is NOT Recommended for Complex Febrile Seizure Prophylaxis
Prophylactic anticonvulsant therapy, including clobazam, is not recommended for children with febrile seizures—whether simple or complex—because the potential toxicities outweigh the relatively minor risks associated with these benign seizures. 1
Why Prophylaxis is Not Recommended
The 2008 American Academy of Pediatrics clinical practice guideline explicitly states that neither continuous nor intermittent anticonvulsant therapy should be used for febrile seizures 1. This recommendation is based on several key factors:
- Febrile seizures are benign: No long-term effects on IQ, neurodevelopment, or mortality have been identified 1
- Low epilepsy risk: Children with simple febrile seizures have approximately the same risk of developing epilepsy as the general population (1-2.5%) 1
- No prevention of epilepsy: Prophylactic treatment does not reduce epilepsy risk, which is likely due to genetic predisposition rather than structural brain damage 1
- High adverse effect burden: Up to 30-45% of children experience side effects from benzodiazepines 2, 3, 4
If Clobazam Were to Be Used (Despite Guidelines)
While not recommended, research studies have used the following dosing when clobazam was administered intermittently during febrile episodes:
Weight-Based Dosing for Intermittent Use 2:
- Up to 5 kg: 5 mg/day
- 5-10 kg: 10 mg/day
- 11-15 kg: 15 mg/day
- Over 15 kg: 20 mg/day
Administration: Given orally at the onset of fever and continued for 48 hours regardless of fever duration 3
Evidence for Clobazam
One small study showed clobazam reduced recurrence from 83.3% to 16.7% at 6 months (RR 0.36,95% CI 0.20-0.64) 5, 6, but this was against an unusually high control recurrence rate and requires replication. The 2017 and 2021 Cochrane reviews noted this single trial result needs confirmation before being considered reliable 5, 6.
Common Pitfalls to Avoid
Don't confuse simple and complex febrile seizures: The AAP guideline specifically addresses simple febrile seizures but explicitly states it is "not intended for patients with complex febrile seizures" 1. However, the fundamental principle remains—prophylaxis is not recommended for either type.
Don't use continuous prophylaxis: If any intervention is considered despite guidelines, only intermittent therapy during febrile episodes has been studied for clobazam—never continuous daily dosing 2, 3
Recognize side effects: Adverse effects occurred in 35.7-45% of children, including hyperactivity, sedation, ataxia, vomiting, irritability, and hypersalivation 2, 3, 4
What TO Do Instead
Parent education and reassurance are the cornerstones of management 7, 1:
- Explain the benign nature and excellent prognosis of febrile seizures
- Provide instructions for fever management with antipyretics (for comfort, not seizure prevention)
- Teach first aid management during seizures
- Ensure parents have adequate medical service contact information
- Consider rectal diazepam for acute seizure termination if seizures are prolonged, but not for prophylaxis 7
Special consideration: In situations of severe parental anxiety, intermittent oral diazepam at fever onset may be discussed, though it still carries a 36% adverse effect rate 1, 6. Clobazam is not the preferred benzodiazepine even in this scenario, as diazepam has more robust evidence.